SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shree Ganesh Remedies informs about outcome of board meeting

01 Jun 2024 Evaluate
Shree Ganesh Remedies has informed that the Board of Directors of the Company as its meeting held on today on Saturday, June 01, 2024 have inter-alia considered and approved following: Audited Financial Results (Standalone and Consolidated) of the company for the quarter and the financial year ended on March 31, 2024, along with the reports of Auditors thereon pursuant to Regulation 33 of SEBI LODR Regulations. Copy of the said Financial Results (Standalone and Consolidated) and Auditors Report is enclosed. Pursuant to Regulation 33 of SEBI LODR Regulations, we hereby declare that the statutory auditors have issued (Standalone and Consolidated) Audit Reports with unmodified opinion on the financial results of the Company for the year ended 31st March, 2024; Re-appointment of VISESH INFOTECNICSVishal Thawani & Associates, Company Secretaries (COP No.: 17377) as a Secretarial Auditors of the Company for the FY 2024-25. Re-appointment of S N D K & Associates LLP, Chartered Accountants (Firm Registration No.: W100060) as an Internal Auditors of the Company for the FY 2024-25. The details required under Regulation 30 of the SEBI LODR Regulations read with SEBI Circular No. SEBI/HO/CFD/CFDPoD1/P/CIR/2023/123 dated July 13, 2023 is provided as an Annexure- A. The Board of Directors Meeting commenced at 12:30 p.m. and concluded at 01:40 pm.

The above information is a part of company’s filings submitted to BSE.

Shree Ganesh Remed. Share Price

533.90 26.70 (5.26%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×